- $496.90m
- $418.00m
- $9.91m
- 55
- 15
- 68
- 43
Annual balance sheet for Nano-X Imaging, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | 20-F | 20-F | 20-F | 6-K |
| Standards: | USG | USG | USG | USG | — |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 8.07 | 213 | 88.7 | 77.6 | 82.4 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | — | — | 1.05 | 0.977 | 1.48 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 9.64 | 220 | 94.9 | 82.5 | 88.6 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.754 | 15.4 | 39.2 | 44.7 | 46.9 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 11.9 | 236 | 363 | 254 | 219 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 20.3 | 4.48 | 52.8 | 25.1 | 15.5 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 20.6 | 5.4 | 71 | 37.3 | 23.1 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -8.78 | 231 | 292 | 217 | 196 |
| Total Liabilities & Shareholders' Equity | 11.9 | 236 | 363 | 254 | 219 |
| Total Common Shares Outstanding |